相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Incretin Hormones on β-Cell Mass and Function, Body Weight, and Hepatic and Myocardial Function
Sunder Mudaliar et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species-Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
Hisko Oeseburg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
GLP-1: What is known, new and controversial in 2010?
R. Burcelin et al.
DIABETES & METABOLISM (2010)
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Solomon Tesfaye et al.
DIABETES CARE (2010)
Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
Patricia L. Brubaker
ENDOCRINOLOGY (2010)
ERK and cell death: ERK1/2 in neuronal death
Srinivasa Subramaniam et al.
FEBS JOURNAL (2010)
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
O. Erdogdu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats
Heung Yong Tin et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease
Bronwen Martin et al.
DIABETES (2009)
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
Nigel A. Calcutt et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Urd Kielgast et al.
CURRENT DIABETES REVIEWS (2009)
Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas
Ditte Tornehave et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Anti-proliferative effect of pro-inflammatory cytokines in cultured β cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition:: protective role of glucagon-like peptide-1
M. Blandino-Rosano et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker et al.
LANCET (2008)
Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice
Kristina K. Beiswenger et al.
NEUROSCIENCE LETTERS (2008)
Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy
Megan S. Johnson et al.
PAIN (2008)
Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
Torsten P. Vahl et al.
ENDOCRINOLOGY (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin
James F. List et al.
REGULATORY PEPTIDES (2006)
The ERK cascade - A prototype of MAPK signaling
H Rubinfeld et al.
MOLECULAR BIOTECHNOLOGY (2005)
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia
KB Degn et al.
DIABETES (2004)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch
AB Malmberg et al.
PAIN (2004)
Cell signalling of the GLP-1 action in rat liver
A Redondo et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
T Perry et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy
NA Calcutt et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy
T Purves et al.
FASEB JOURNAL (2001)
分享论文
